Daniel Bazarko - Net Worth and Insider Trading

Daniel Bazarko Net Worth

The estimated net worth of Daniel Bazarko is at least $6 Million dollars as of 2024-04-29. Daniel Bazarko is the SVP, Controller, CAO of Alexion Pharmaceuticals Inc and owns about 30,883 shares of Alexion Pharmaceuticals Inc (ALXN) stock worth over $6 Million. Details can be seen in Daniel Bazarko's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Daniel Bazarko has not made any transactions after 2020-12-17 and currently still holds the listed stock(s).

Transaction Summary of Daniel Bazarko

To

Daniel Bazarko Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Daniel Bazarko owns 1 companies in total, including Alexion Pharmaceuticals Inc (ALXN) .

Click here to see the complete history of Daniel Bazarko’s form 4 insider trades.

Insider Ownership Summary of Daniel Bazarko

Ticker Comapny Transaction Date Type of Owner
ALXN Alexion Pharmaceuticals Inc 2020-12-17 SVP & Controller & CAO

Daniel Bazarko Latest Holdings Summary

Daniel Bazarko currently owns a total of 1 stock. Daniel Bazarko owns 30,883 shares of Alexion Pharmaceuticals Inc (ALXN) as of December 17, 2020, with a value of $6 Million.

Latest Holdings of Daniel Bazarko

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
ALXN Alexion Pharmaceuticals Inc 2020-12-17 30,883 182.50 5,636,148

Holding Weightings of Daniel Bazarko


Daniel Bazarko Form 4 Trading Tracker

According to the SEC Form 4 filings, Daniel Bazarko has made a total of 1 transactions in Alexion Pharmaceuticals Inc (ALXN) over the past 5 years, including 0 buys and 1 sells. The most-recent trade in Alexion Pharmaceuticals Inc is the sale of 24,066 shares on December 17, 2020, which brought Daniel Bazarko around $4 Million.

Insider Trading History of Daniel Bazarko

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Daniel Bazarko Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Daniel Bazarko Ownership Network

Ownership Network List of Daniel Bazarko

No Data

Ownership Network Relation of Daniel Bazarko


Daniel Bazarko Owned Company Details

What does Alexion Pharmaceuticals Inc do?

Who are the key executives at Alexion Pharmaceuticals Inc?

Daniel Bazarko is the SVP & Controller & CAO of Alexion Pharmaceuticals Inc. Other key executives at Alexion Pharmaceuticals Inc include EVP & CCAO Tanisha Carino , EVP & Chief Commercial Officer Brian Goff , and EVP & Research & Development John J Orloff .

Alexion Pharmaceuticals Inc (ALXN) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Alexion Pharmaceuticals Inc (ALXN) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Alexion Pharmaceuticals Inc (ALXN) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Alexion Pharmaceuticals Inc (ALXN)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Alexion Pharmaceuticals Inc Insider Transactions

No Available Data

Daniel Bazarko Mailing Address

Above is the net worth, insider trading, and ownership report for Daniel Bazarko. You might contact Daniel Bazarko via mailing address: C/o Alexion Pharmaceuticals, Inc. 121 Seaport Boulevard Boston Ma 02210.

Discussions on Daniel Bazarko

No discussions yet.